DrugBiological
Ontuxizumab clinical trials
Also written MORAb-004.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2012 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses ontuxizumab is read from its arms, and is right about nine times in ten.
Testing it · 6
- Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)TerminatedPhase 2MorphotekNCT01507545Written as MORAb-004
- Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic MelanomaCompletedPhase 2Eisai Inc.NCT01335009Written as MORAb-004 (monoclonal antibody)
- Sarcoma Study of MORAb-004 Utilization: Research and Clinical EvaluationCompletedPhase 2MorphotekNCT01574716Written as MORAb-004
- A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103)CompletedPhase 1Eisai Co., Ltd.NCT01773434Written as MORAb-004
- MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaCompletedPhase 1MorphotekNCT01748721Written as anti-endosialin/TEM1 monoclonal antibody MORAb-004
- A Study of of MORAb-004 in Subjects With Solid TumorsCompletedPhase 1MorphotekNCT00847054Written as MORAb-004 (monoclonal antibody to TEM1)
Codes
What other systems call ontuxizumab · ClinicalTrials.gg INT000390
- MeSH (NLM) C000604563ontuxizumabOne source NLM
- UNII (FDA) 0M2XT000YCONTUXIZUMABConfirmed FDA, NLM, Wikidata
- Wikidata Q15708295OntuxizumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C82406OntuxizumabOne source FDA
- DrugBank DB16270One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000604563 | ontuxizumab | One source NLM |
| UNII (FDA) | 0M2XT000YC | ONTUXIZUMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15708295 | Ontuxizumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C82406 | Ontuxizumab | One source FDA |
| DrugBank | DB16270 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.